A small-molecule targeted therapy differs from a monoclonal antibody because:
Show answer and explanation
Correct answer: Small molecules enter cells and inhibit intracellular targets
Small-molecule targeted therapies are designed to penetrate cells and inhibit intracellular proteins or signalling pathways; monoclonal antibodies usually target extracellular or cell-surface molecules.
Practice all 20 Immunotherapy and Targeted Therapy questions
Keep practicing
More Immunotherapy and Targeted Therapy questions
- Which of the following is true regarding patient selection for targeted therapy?
- The term “durable response” in cancer immunotherapy means:
- Which of the following is a potential limitation of targeted therapy?
- Which of the following best describes “on-target off-tumour” toxicity in targeted therapy?
- A patient being considered for targeted therapy should have which of the following performed?
- A nurse monitors a patient on immunotherapy for signs of “cytokine release syndrome” (CRS). This adverse effect is most often associated wi…